Sunshine Biopharma Inc. (SBFM) › Shareholders' EquitySunshine Biopharma Inc. (SBFM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $97.8K2010: $196.2K2011: $103.0K2012: $70.4K2013: -$7.7K2014: -$387.6K2015: -$597.0K2016: -$209.7K2017: -$573.4K2018: -$55.8K2019: -$735.4K2020: -$954.8K2021: $211.7K2022: $21.63M2023: $21.21M2024: $23.50M2025: $23.04M$23.04M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$23.04M-2.0%2024$23.50M+10.8%2023$21.21M-1.9%2022$21.63M+10118.0%2021$211.7K+122.2%2020-$954.8K-29.8%2019-$735.4K-1219.0%2018-$55.8K+90.3%2017-$573.4K-173.4%2016-$209.7K+64.9%2015-$597.0K-54.0%2014-$387.6K-4927.0%2013-$7.7K-110.9%2012$70.4K-31.6%2011$103.0K-47.5%2010$196.2K+100.6%2009$97.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share